iSpecimen (ISPC) Cash from Financing Activities (2020 - 2025)
iSpecimen (ISPC) posted quarterly Cash from Financing Activities of $5.0 million for Q4 2025, up 32.94% year-over-year from $3.8 million in Q4 2024, and down 4.1% on a QoQ basis from $5.2 million in Q3 2025.
iSpecimen (ISPC) Cash from Financing Activities (2020 - 2025) Analysis & Trends
iSpecimen (ISPC) has reported Cash from Financing Activities for 6 consecutive years, with $5.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Financing Activities rose 32.94% year-over-year to $5.0 million; the TTM figure through Dec 2025 stood at $14.9 million (up 155.66% YoY), while the FY2025 annual figure was $10.2 million, up 76.04% from the prior year.
- Cash from Financing Activities came in at $5.0 million for Q4 2025 at iSpecimen, down from $5.2 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $19.6 million in Q4 2021, with the low at -$3.5 million in Q4 2022.
- Average Cash from Financing Activities over 5 years is $2.5 million, with a median of $467628.5 recorded in 2022.
- The largest YoY upside for Cash from Financing Activities was 41304.5% in 2024 against a maximum downside of 275.47% in 2024.
- Year by year, Cash from Financing Activities stood at $19.6 million in 2021, then tumbled by 117.88% to -$3.5 million in 2022, then surged by 100.09% to $3153.0 in 2023, then jumped by 119541.45% to $3.8 million in 2024, then surged by 32.94% to $5.0 million in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $5.0 million, $5.2 million, and $3.8 million for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | iSpecimen | 931,959.22 | -1.89 Mn | -1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.02 Mn |
| Dec 31, 2025 | 5.02 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | 859,980.00 |
| Sep 30, 2024 | 859,980.00 |
| Jun 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | -118,858.00 |
| Mar 31, 2024 | -118,858.00 |
| Jun 30, 2023 | 3,153.00 |
| Jun 30, 2023 | 3,153.00 |
| Mar 31, 2023 | 67,736.00 |
| Mar 31, 2023 | 67,736.00 |
| Dec 31, 2022 | -3.50 Mn |
| Dec 31, 2022 | -3.50 Mn |
| Sep 30, 2022 | -4,967.00 |
| Sep 30, 2022 | -4,967.00 |